Correlation Between Soleno Therapeutics and Telomir Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Soleno Therapeutics and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on Soleno Therapeutics and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Telomir Pharmaceuticals,.

Diversification Opportunities for Soleno Therapeutics and Telomir Pharmaceuticals,

-0.3

Correlation Coefficient

Soleno Therapeutics  Telomir Pharmaceuticals,

Very good diversification

The 3 months correlation between Soleno and Telomir is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Soleno Therapeutics and Telomir Pharmaceuticals,

Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 0.72 times more return on investment than Telomir Pharmaceuticals,. However, Soleno Therapeutics is 1.39 times less risky than Telomir Pharmaceuticals,. It trades about 0.07 of its potential returns per unit of risk. Telomir Pharmaceuticals, Common is currently generating about 0.03 per unit of risk. If you would invest  4,495  in Soleno Therapeutics on October 23, 2024 and sell it today you would earn a total of  193.00  from holding Soleno Therapeutics or generate 4.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Soleno Therapeutics  vs.  Telomir Pharmaceuticals, Commo

Soleno Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Soleno Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Telomir Pharmaceuticals,

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Telomir Pharmaceuticals, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady essential indicators, Telomir Pharmaceuticals, displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Soleno Therapeutics and Telomir Pharmaceuticals,

The main advantage of trading using opposite Soleno Therapeutics and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.

The idea behind Soleno Therapeutics and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.